An official website of the United States government Here's how you know

U.S. Department of Health and Human Services | National Institutes of Health

Official websites use .gov
A .gov website belongs to an official government
organization in the United States.

Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.

PAR-22-131 - Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions	NOT-CA-20-044	NCI	Apr 9, 2020	May 8, 2023	R03, R21, R01, P01

For technical issues E-mail OER Webmaster

Redirect Notice

PAR-22-131 - Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Stay Connected

Government Sites

Web Policies and Notices

Site Map